medigraphic.com
Colegio de Medicina Interna de México.

2022, Number 5

<< Back Next >>

Med Int Mex 2022; 38 (5)

Pleural tuberculosis, a report of a case in the Regional Hospital of San Gil, Santander, Colombia

González-Garcés HJ, Reyes A, López JS

Language: Spanish
References: 22
Page: 1113-1118
PDF size: 196.14 Kb.


ABSTRACT

Background: Pleural tuberculosis is characterized by a severe inflammatory process that leads to the formation of an exudative pleural effusion due to the increased permeability of the pleural capillaries and obstruction of the lymphatics of the parietal pleura. Its clinical presentation is predominantly atypical, so it represents a challenge for an accurate diagnosis and optimal treatment for patients
Clinical case: A 53-year-old male patient with tuberculous pleural effusion and a history of chronic alcohol consumption without medication, who was admitted with signs and symptoms of water congestion, so we focused on symptoms such as decompensated heart failure vs anasarca due to hypoalbuminemia. A pleural effusion highlighted that occupied two thirds parts of the right hemithorax, so diuretic therapy was started without improvement on the third day of treatment, evidenced due to persistent pleural effusion in a high-resolution chest tomography, which required performing a diagnostic and therapeutic thoracentesis, documenting exudative lymphocytic pleural effusion with positive bacilloscopy in pleural fluid.
Conclusions: Pleural effusion is common in routine medical practice and can be due to many underlying diseases, among these, pleural tuberculosis. Therefore, it is always necessary to approach and study the pleural fluid, individualizing the patient and using the appropriate diagnostic tests.


REFERENCES

  1. WHO. Global tuberculosis report (2016). www.who.int/tb/publications/global_report.

  2. Light RW. Update on tuberculous pleural effusion.Respirology 2010; 15 (3): 451-458. doi: 10.1111/j.1440-1843.2010.01723.x.

  3. Porcel JM. Tuberculous pleural effusion. Lung 2009; 187:263-270. doi: 10.1007/s00408-009-9165-3.

  4. Mlika-Cabanne N, Brauner M, Kamanfu G, Grenier P, et al.Radiographic abnormalities in tuberculosis and risk of coexistinghuman immunodeficiency virus infection. Methodsand preliminary results from Bujumbura, Burundi. Am JRespir Crit Care Med 1995; 152: 794-799. doi: 10.1164/ajrccm.152.2.7633744.

  5. Lopez MP. Informe de evento tuberculosis, Colombia,2017. Versión 3. Instituto Nacional de Salud. 20/04/2018.Pag 11/21.

  6. Trajman A, Pai M, Dheda K, van Zyl-Smit R, et al. Novel testsfor diagnosing tuberculous pleural effusion: what worksand what does not? Eur Respir J 2008; 31:1098-1106. doi:10.1183/09031936.00147507.

  7. Berger HW, Mejia E. Tuberculous pleurisy. Chest 1973; 63:

  8. 88-92. doi: 10.1378/chest.63.1.88.8. Valdés L, Alvarez D, San José E, Penela P, et al. Tuberculouspleurisy: a study of 254 patients. Arch Intern Med 1998;158: 2017-21. doi: 10.1001/archinte.158.18.2017.

  9. Porcel JM, Vives M. Etiology and pleural fluid characteristicsof large and massive effusions. Chest 2003; 124: 978-83.https://doi.org/10.1378/chest.124.3.978.

  10. Seibert AF, Haynes J Jr, Middleton R, Bass JB Jr. Tuberculouspleural effusion. Twenty-year experience. Chest 1991; 99:883-886. doi: 10.1378/chest.99.4.883.

  11. Ko JM, Park HJ, Kim CH. Pulmonary changes of pleural TB:up-to-date CT imaging. Chest 2014; 146: 1604-11. doi:10.1378/chest.14-0196.

  12. Gopi A, Madhavan SM, Sharma SK, Sahn SA. Diagnosis andtreatment of tuberculous pleural effusion in 2006. Chest2007; 131: 880-889. doi: 10.1378/chest.06-2063.

  13. Koh WJ. Progression of tuberculous pleurisy: From alymphocyte-predominant free-flowing effusion to a neutrophil-predominant loculated effusion. Tuberc Respir Dis2017; 80: 90-92. https://doi.org/10.4046/trd.2017.80.1.90.

  14. Ruan SY, Chuang YC, Wang JY, Lin JW, et al. Revisiting tuberculouspleurisy: pleural fluid characteristics and diagnosticyield of mycobacterial culture in an endemic area. Thorax2012; 67: 822-827. doi: 10.1136/thoraxjnl-2011-201363.

  15. Vorster MJ, Allwood BW, Diacon AH, Koegelenberg CF.Tuberculous pleural effusions: advances and controversies.J Thorac Dis 2015; 7: 981-991. doi: 10.3978/j.issn.2072-1439.2015.02.18.

  16. Siddiqi K, Lambert ML, Walley J. Clinical diagnosis of smearnegative pulmonary tuberculosis in low-income countries:the current evidence. Lancet Infect Dis 2003; 3: 288-296.http://dx.doi.org/10.1016/S1473 -3099(03)00609-1.

  17. Gill MK, Kukreja S, Chhabra N. Evaluation of nested polymerasechain reaction for rapid diagnosis of clinicallysuspected tuberculous pleurisy. J. Clin Diagn Res 2013;7 (11): 2456-2458. doi: 10.7860/JCDR/2013/6255.3577.

  18. Villegas MV, Labrada LA, Saravia NG. Evaluation of polymerasechain reaction, adenosine deaminase, and interferongammain pleural fluid for the differential diagnosis ofpleural tuberculosis. Chest 2000; 118 (5): 1355-1364. doi:10.1378/chest.118.5.1355.

  19. Guidelines for treatment of drug-susceptible tuberculosisand patient care, 2017 update. Geneva: World HealthOrganization; 2017. License: CC BY-NC-SA 3.0 IGO.

  20. Sharma SK, Ryan H, Khaparde S, Sachdeva KS, et al. Index-TB guidelines: Guidelines on extrapulmonary tuberculosisfor India. Indian J Med Res 2017; 145: 448-463 DOI:10.4103/ijmr.IJMR_1950_16.

  21. Engel ME, Matchaba PT, Volmink J. Corticosteroids fortuberculous pleurisy. Cochrane Database Syst Rev 2007;4: CD001876. doi: 10.1002/14651858.CD001876.pub2.

  22. Kwak SM, Park CS, Cho JH, Ryu JS, et al. The effects ofurokinase instillation therapy via percutaneous transthoraciccatheter in loculated tuberculous pleural effusion:a randomized prospective study. Yonsei Med J 2004; 45:822-8. doi: 10.3349/ymj.2004.45.5.822.




2020     |     www.medigraphic.com